** Shares of medical devices maker Nanosonics NAN.AX fall 4.3% to A$4.64
** Bell Potter forecasts additional A$2.5 million ($1.59 million) to co's costs in FY26 due to U.S. tariffs on Australia
** Also sees co's new 'CORIS' devices to have minimal contribution to revenue in FY26
** Downgrades FY26 and FY27 earnings by 9%; reduces PT to A$4.05 from A$4.06
** Three analysts rate the stock "buy", 4 "hold" and 2 "sell"; their median PT is A$4.78 – LSEG data
** Stock trims YTD gains to 52.8%
($1 = 1.5726 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。